Central obesity and risks of pre- and postmenopausal breast cancer: a dose–response meta-analysis of prospective studies

Obesity Reviews

Volumn 17, Issue 11, 2016, Pages 1167-1177

  Chen, G C ^a   Chen, S J ^b   Zhang, R ^a   Hidayat, K ^a   Qin, J B ^c   Zhang, Y S ^b   Qin, L Q ^a  

^a SOOCHOW UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^c Maternal and Child Health Hospital of Hunan Province   (China)

Author keywords

Breast cancer; central obesity; waist circumference; waist to hip ratio

Indexed keywords

HORMONE;

BREAST CANCER; CANCER RISK; CONFIDENCE INTERVAL; DATA BASE; EMBASE; HORMONE SUBSTITUTION; HUMAN; OBESITY; POSTMENOPAUSE; PREMENOPAUSE; PROSPECTIVE STUDY; PUBLICATION; PUBLISHING; REVIEW; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

EID: 84990821369     PISSN: 14677881     EISSN: 1467789X     Source Type: Journal    
DOI: 10.1111/obr.12443     Document Type: Review

References (63)

1. Global Burden of Disease Cancer C, Fitzmaurice C, Dicker D et al. The Global Burden of Cancer 2013. JAMA Oncol 2015; 1: 505–527.
2. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008; 371: 569–578.
3. Amadou A, Ferrari P, Muwonge R et al. Overweight, obesity and risk of premenopausal breast cancer according to ethnicity: a systematic review and dose–response meta-analysis. Obes Rev 2013; 14: 665–678.
4. Rose DP, Gracheck PJ, Vona-Davis L. The interactions of obesity, inflammation and insulin resistance in breast cancer. Cancers (Basel) 2015; 7: 2147–2168.
5. James FR, Wootton S, Jackson A, Wiseman M, Copson ER, Cutress RI. Obesity in breast cancer—what is the risk factor? Eur J Cancer 2015; 51: 705–720.
6. Phillips LK, Prins JB. The link between abdominal obesity and the metabolic syndrome. Curr Hypertens Rep 2008; 10: 156–164.
7. Endogenous H, Breast Cancer Collaborative G, Key TJ, Appleby PN, Reeves GK, Roddam AW. Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol 2010; 11: 530–542.
8. Sieri S, Muti P, Claudia A et al. Prospective study on the role of glucose metabolism in breast cancer occurrence. Int J Cancer 2012; 130: 921–929.
9. Khan S, Shukla S, Sinha S, Meeran SM. Role of adipokines and cytokines in obesity-associated breast cancer: therapeutic targets. Cytokine Growth Factor Rev 2013; 24: 503–513.
10. Belardi V, Gallagher EJ, Novosyadlyy R, LeRoith D. Insulin and IGFs in obesity-related breast cancer. J Mammary Gland Biol Neoplasia 2013; 18: 277–289.
11. Harvie M, Hooper L, Howell AH. Central obesity and breast cancer risk: a systematic review. Obes Rev 2003; 4: 157–173.
12. World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. WCRF/AICR: Washington, DC, 2007.
13. Suzuki R, Orsini N, Saji S, Key TJ, Wolk A. Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status—a meta-analysis. Int J Cancer 2009; 124: 698–712.
14. Ahn J, Schatzkin A, Lacey JV Jr et al. Adiposity, adult weight change, and postmenopausal breast cancer risk. Arch Intern Med 2007; 167: 2091–2102.
15. Canchola AJ, Anton-Culver H, Bernstein L et al. Body size and the risk of postmenopausal breast cancer subtypes in the California Teachers Study cohort. Cancer Causes Control 2012; 23: 473–485.
16. Catsburg C, Kirsh VA, Soskolne CL et al. Associations between anthropometric characteristics, physical activity, and breast cancer risk in a Canadian cohort. Breast Cancer Res Treat 2014; 145: 545–552.
17. Fagherazzi G, Chabbert-Buffet N, Fabre A et al. Hip circumference is associated with the risk of premenopausal ER-/PR- breast cancer. Int J Obes (Lond) 2012; 36: 431–439.
18. Gaudet MM, Carter BD, Patel AV, Teras LR, Jacobs EJ, Gapstur SM. Waist circumference, body mass index, and postmenopausal breast cancer incidence in the Cancer Prevention Study-II Nutrition Cohort. Cancer Causes Control 2014; 25: 737–745.
19. Harris HR, Willett WC, Terry KL, Michels KB. Body fat distribution and risk of premenopausal breast cancer in the Nurses' Health Study II. J Natl Cancer Inst 2011; 103: 273–278.
20. Huang Z, Willett WC, Colditz GA et al. Waist circumference, waist:hip ratio, and risk of breast cancer in the Nurses' Health Study. Am J Epidemiol 1999; 150: 1316–1324.
21. Kaaks R, Van Noord PA, Den Tonkelaar I, Peeters PH, Riboli E, Grobbee DE. Breast-cancer incidence in relation to height, weight and body-fat distribution in the Dutch “DOM” cohort. Int J Cancer 1998; 76: 647–651.
22. Krebs EE, Taylor BC, Cauley JA, Stone KL, Bowman PJ, Ensrud KE. Measures of adiposity and risk of breast cancer in older postmenopausal women. J Am Geriatr Soc 2006; 54: 63–69.
23. Lahmann PH, Hoffmann K, Allen N et al. Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer And Nutrition (EPIC). Int J Cancer 2004; 111: 762–771.
24. Li HL, Gao YT, Li Q, Liu DK. Anthropometry and female breast cancer: a prospective cohort study in urban Shanghai. Zhonghua Liu Xing Bing Xue Za Zhi 2006; 27: 488–493.
25. Macinnis RJ, English DR, Gertig DM, Hopper JL, Giles GG. Body size and composition and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 2004; 13: 2117–2125.
26. Muti P, Stanulla M, Micheli A et al. Markers of insulin resistance and sex steroid hormone activity in relation to breast cancer risk: a prospective analysis of abdominal adiposity, sebum production, and hirsutism (Italy). Cancer Causes Control 2000; 11: 721–730.
27. Palmer JR, Adams-Campbell LL, Boggs DA, Wise LA, Rosenberg L. A prospective study of body size and breast cancer in black women. Cancer Epidemiol Biomarkers Prev 2007; 16: 1795–1802.
28. Phipps AI, Chlebowski RT, Prentice R et al. Body size, physical activity, and risk of triple-negative and estrogen receptor-positive breast cancer. Cancer Epidemiol Biomarkers Prev 2011; 20: 454–463.
29. Sellers TA, Davis J, Cerhan JR et al. Interaction of waist/hip ratio and family history on the risk of hormone receptor-defined breast cancer in a prospective study of postmenopausal women. Am J Epidemiol 2002; 155: 225–233.
30. Sonnenschein E, Toniolo P, Terry MB et al. Body fat distribution and obesity in pre- and postmenopausal breast cancer. Int J Epidemiol 1999; 28: 1026–1031.
31. White AJ, Nichols HB, Bradshaw PT, Sandler DP. Overall and central adiposity and breast cancer risk in the Sister Study. Cancer 2015; 121: 3700–3708.
32. Keum N, Greenwood DC, Lee DH et al. Adult weight gain and adiposity-related cancers: a dose–response meta-analysis of prospective observational studies. J Natl Cancer Inst 2015; 107.
33. Wells GA, Shea B, O'Connell D, et al. The Newcastle–Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses, 2013. wwwohrica/programs/clinical_epidemiology/oxfordhtm.
34. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177–188.
35. Greenland S, Longnecker MP. Methods for trend estimation from summarized dose–response data, with applications to meta-analysis. Am J Epidemiol 1992; 135: 1301–1309.
36. Orsini N, Bellocco R, Greenland S. Generalized least squares for trend estimation of summarized dose–response data. Stata J 2006; 6: 40–57.
37. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539–1558.
38. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629–634.
39. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088–1101.
40. Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000; 56: 455–463.
41. Folsom AR, Kaye SA, Prineas RJ, Potter JD, Gapstur SM, Wallace RB. Increased incidence of carcinoma of the breast associated with abdominal adiposity in postmenopausal women. Am J Epidemiol 1990; 131: 794–803.
42. Folsom AR, Kushi LH, Anderson KE et al. Associations of general and abdominal obesity with multiple health outcomes in older women: the Iowa Women's Health Study. Arch Intern Med 2000; 160: 2117–2128.
43. Poynter JN, Inoue-Choi M, Ross JA, Jacobs DR Jr, Robien K. Reproductive, lifestyle, and anthropometric risk factors for cancer in elderly women. Cancer Epidemiol Biomarkers Prev 2013; 22: 681–687.
44. Sweeney C, Blair CK, Anderson KE, Lazovich D, Folsom AR. Risk factors for breast cancer in elderly women. Am J Epidemiol 2004; 160: 868–875.
45. Kabat GC, Kim M, Chlebowski RT et al. A longitudinal study of the metabolic syndrome and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 2009; 18: 2046–2053.
46. Morimoto LM, White E, Chen Z et al. Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States). Cancer Causes Control 2002; 13: 741–751.
47. Rohan TE, Heo M, Choi L et al. Body fat and breast cancer risk in postmenopausal women: a longitudinal study. J Cancer Epidemiol 2013; 2013: 754815.
48. Reeves KW, McLaughlin V, Fredman L, Ensrud K, Cauley JA. Components of metabolic syndrome and risk of breast cancer by prognostic features in the study of osteoporotic fractures cohort. Cancer Causes Control 2012; 23: 1241–1251.
49. den Tonkelaar I, Seidell JC, Collette HJ, de Waard F. A prospective study on obesity and subcutaneous fat patterning in relation to breast cancer in post-menopausal women participating in the DOM project. Br J Cancer 1994; 69: 352–357.
50. Borgquist S, Jirstrom K, Anagnostaki L, Manjer J, Landberg G. Anthropometric factors in relation to different tumor biological subgroups of postmenopausal breast cancer. Int J Cancer 2009; 124: 402–411.
51. Lahmann PH, Lissner L, Gullberg B, Olsson H, Berglund G. A prospective study of adiposity and postmenopausal breast cancer risk: the Malmo Diet and Cancer Study. Int J Cancer 2003; 103: 246–252.
52. Mellemkjaer L, Bigaard J, Tjonneland A et al. Body composition and breast cancer in postmenopausal women: a Danish prospective cohort study. Obesity (Silver Spring) 2006; 14: 1854–1862.
53. Ritte R, Lukanova A, Berrino F et al. Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study. Breast Cancer Res 2012; 14: R76.
54. Tehard B, Clavel-Chapelon F. Several anthropometric measurements and breast cancer risk: results of the E3N cohort study. Int J Obes (Lond) 2006; 30: 156–163.
55. Wu MH, Chou YC, Yu JC et al. Hormonal and body-size factors in relation to breast cancer risk: a prospective study of 11,889 women in a low-incidence area. Ann Epidemiol 2006; 16: 223–229.
56. Liu Y, Warren Andersen S, Wen W et al. Prospective cohort study of general and central obesity, weight change trajectory, and risk of major cancers among Chinese women. Int J Cancer 2016. doi:10.1002/ijc.30187
57. Rose DP, Vona-Davis L. Interaction between menopausal status and obesity in affecting breast cancer risk. Maturitas 2010; 66: 33–38.
58. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004; 4: 579–591.
59. Potter JD, Cerhan JR, Sellers TA et al. Progesterone and estrogen receptors and mammary neoplasia in the Iowa Women's Health Study: how many kinds of breast cancer are there? Cancer Epidemiol Biomarkers Prev 1995; 4: 319–326.
60. Setiawan VW, Monroe KR, Wilkens LR, Kolonel LN, Pike MC, Henderson BE. Breast cancer risk factors defined by estrogen and progesterone receptor status: the multiethnic cohort study. Am J Epidemiol 2009; 169: 1251–1259.
61. Suzuki R, Rylander-Rudqvist T, Ye W, Saji S, Wolk A. Body weight and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status among Swedish women: a prospective cohort study. Int J Cancer 2006; 119: 1683–1689.
62. Bertolini F, Orecchioni S, Petit JY, Kolonin MG. Obesity, proinflammatory mediators, adipose tissue progenitors, and breast cancer. Curr Opin Oncol 2014; 26: 545–550.
63. Freeman EW, Sammel MD, Lin H, Gracia CR. Obesity and reproductive hormone levels in the transition to menopause. Menopause 2010; 17: 718–726.